Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Lovenox (Enoxaparin Sodium) – Treatment for Deep Vein Thrombosis (DVT)

Drug (Brand / Generic)

Lovenox / enoxaparin sodium

Company / Licensee

Sanofi-Aventis

Therapy Class

Anti-thrombotic

Current Indication

Deep vein thrombosis (DVT), ischemic complications of unstable angina and acute ST-segment elevation myocardial infarction

Market Sector

Cardiovascular

Development Status

Approved in US (generic version approved in July 2010)
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM

Go Top